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Community-Dwelling Adults
Jeanine M. Van Ancum, MD1, Carel G. M. Meskers, MD, PhD1,
Esmee M. Reijnierse, PhD2, Suey S. Y. Yeung, MSc1,2,
Nini H. Jonkman, PhD1, Marijke C. Trappenburg, MD PhD1,3,
Mirjam Pijnappels, PhD1, and Andrea B. Maier, MD PhD1,2
Abstract
Objective: Sarcopenia is highly prevalent in older adults. Knowledge among community-dwelling adults is important for
effective prevention and treatment of sarcopenia. This study aims to assess current knowledge about sarcopenia, investigate
willingness for treatment and prevention, and awareness of muscle health. Method: Participants who attended health ed-
ucational events completed a questionnaire on knowledge about sarcopenia. Self-perceived muscle health was assessed by visual
analog scale. Objective muscle measures included muscle mass, handgrip strength, and gait speed.Results: Included participants
were 197 (median aged 67.9 years [interquartile range = 57.0-75.1]). Eighteen participants (9%) reported to know what
sarcopenia is. Participants’ self-perceived muscle health showed a low correlation with all objective muscle measures. 76% were
willing, in case of sarcopenia diagnosis, to start treatment and 71% were willing to prevent sarcopenia.Discussion: Knowledge
about sarcopenia is limited while participants were willing to start treatment and prevention. Strategies to increase knowledge
among community-dwelling adults are needed.
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Introduction
Sarcopenia affects up to 36% of community-dwelling adults
aged 60 years and older (Shafiee et al., 2017), and the
prevalence is expected to increase in the coming decades
(Ethgen, Beaudart, Buckinx, Bruyère, & Reginster, 2017).
Proposed definitions of sarcopenia include a combination of
low muscle mass, low muscle strength, and/or low gait speed
(Cruz-Jentoft et al., 2010; Vandervoot & Symons, 2001;
Waters, Baumgartner, & Garry, 2000). Muscle mass and
strength start to decline around the third decade of life, with
an acceleration from the fifth decade onward (Beenakker
et al., 2010; Doherty, 2001). In community-dwelling older
adults, sarcopenia is associated with adverse outcomes such
as falls (Landi et al., 2012), fractures (Yu, Leung, & Woo,
2014), institutionalization and hospitalization (Tang et al.,
2018), functional dependency (Dos Santos, Cyrino, Antunes,
Santos, & Sardinha, 2017), and mortality (Brown, Harhay, &
Harhay, 2016). Due to the high prevalence and negative health
outcomes, the economic burden on health care is excessive
(Janssen, Shepard, Katzmarzyk, & Roubenoff, 2004). Pre-
venting the development of sarcopenia in community-dwelling
adults appears crucial and achievable (Beaudart et al., 2017).
Modifiable risk factors in the prevention and treatment of
sarcopenia include malnutrition (Boirie, Morio, Caumon, &
Cano, 2014) and low physical activity (English & Paddon-
Jones, 2010). For prevention, early diagnosis and timely
treatment of sarcopenia, knowledge among health care pro-
fessionals along with community-dwelling adults is a prerequisite.
The recognition of sarcopenia as a disease in September
2016 with the assignment of an International Classification
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of Disease Clinical Modification code (ICD-10-CM-code;
Anker, Morley, & von Haehling, 2016), should advocatemore
awareness of sarcopenia among health care professionals.
However, recent results revealed that only one tenth to one fifth
of health care professionals attending educational events
(“Sarcopenia Road Show”) in the Netherlands, Australia, and
New Zealand know how to formally diagnose sarcopenia
(Reijnierse, de van der Schueren, et al., 2017; Yeung et al.,
unpublished data). Improving knowledge and awareness about
sarcopenia among community-dwelling adults may be just as
important to increase adherence and motivation to lifestyle
changes.
In this study, we aimed to describe the current knowledge
about sarcopenia in a cohort of community-dwelling adults
attending health educational events, to investigate the will-
ingness for treatment and prevention, and to assess the
awareness of muscle health by correlating self-perceived
muscle health with objective muscle measures.
Materials and Methods
Design
A total of 377 community-dwelling adults aged 18 years and
older visited health educational events in 2017 and 2018 at
three different locations in the Netherlands: (a) Philips Veterans
meeting at the Academisch Genootschap, Eindhoven, (b) VU
University Medical Center, Amsterdam, (c) Amstelland
Hospital, Amstelveen. A total of 197 (58.5%) volunteered to
participate in the current study. All participants visiting the
health educational events were invited to participate in the
inception cohort, no exclusion criteria were applied. All
questionnaires and measurements were completed before
commencement of the health educational event. Participants
did not receive any information about sarcopenia before
participating in the study. The research complies with the
ethical rules for human experimentation that are stated in the
Declaration of Helsinki, and was approved by the medical
ethical committee of the VU University Medical Center,
Amsterdam, by the Scientific and Ethical Review Board of the
Vrije Universiteit Amsterdam, and by the medical ethical
committee of the Amstelland Hospital, Amstelveen. All par-
ticipants provided written informed consent.
Data Collection
Characteristics. The questionnaire on characteristics com-
prised of self-reported questions on age in years, sex, re-
tirement (yes or no), career in health care (yes or no, including
previous career), years of education (including day-care, pri-
mary school and part time study), current smoking (yes or no),
current alcohol consumption (yes or no), if participants are
performing muscle strengthening exercises ≥ 2 times a week
(yes or no), if participants are performing moderate-vigorous
activities ≥ 150 min a week (yes or no), use of walking aid (yes
or no), self-reported difficulty walking 100 m (yes or no),
experienced any falls in the last 12 months (yes or no), ex-
periencing self-reported balance problems (yes or no), if
participants need any help performing activities of daily living
(ADL; yes or no), number of medications and morbidities.
Morbidities included asthma or chronic obstructive pulmonary
disease, hypertension, cerebrovascular accident, arthrosis or
rheumatoid osteoarthritis, Parkinson, malignancy, diabetes,
myocardial infarction. Height (in cm) and weight (in kg) were
measured using a standard standing ruler and weight scale, and
body mass index (BMI, in kg/m2) was calculated.
Sarcopenia awareness questionnaire. A sarcopenia awareness
questionnaire was developed by the authors during several
expert meetings, and the questionnaire was subsequently
tested in n = 10 community-dwelling adults aged 60 years and
older to test face validity of the questionnaire. We included
older adults to test the questionnaire, as predominantly older
adults were expected to attend the health educational events.
The questionnaire was translated to Dutch, and comprised of
questions on terminology, etiology, consequences, treatment
and prevention of sarcopenia (see Supplementary Material).
After answering questions about terminology, the European
Working Group on Sarcopenia in Older People (EWGSOP)
definition of sarcopenia was introduced (low muscle mass,
low muscle strength, and/or low physical performance; Cruz-
Jentoft et al., 2010). Questions mostly comprised multiple-
choice answers with an additional open option. Among the
multiple-choice options, three correct answers for the etiol-
ogy of sarcopenia were provided, including aging (Tieland,
Trouwborst, & Clark, 2018), malnutrition (Boirie et al., 2014)
and physical inactivity (English & Paddon-Jones, 2010), and
three correct consequences were provided, including falls
(Landi et al., 2012), fractures (Yu et al., 2014), and admission
to a nursing home (Tang et al., 2018). After answering
questions on etiology, consequences, and treatment, the
participants were informed about appropriate treatment of
sarcopenia (high protein intake and muscle strength training;
Montero-Fernandez & Serra-Rexach, 2013; Paddon-Jones &
Rasmussen, 2009; Peterson, Rhea, Sen, & Gordon, 2010).
Participants were asked to rate their self-perceived muscle
health and to judge the importance of muscle for overall
health, the contribution of muscle to independency at older
age, and the contribution of physical activity and nutrition in
maintenance of muscle. It was scored using a 100-mm visual
analog scale (VAS; McCormack, Horne, & Sheather, 1988)
with higher scores implying higher importance of the item.
Objective muscle measures. All objective muscle measures
were performed in the same measurement room by trained
research staff. Muscle mass was assessed using direct
segmental multifrequency bioelectrical impedance analysis
(DSM-BIA; In-Body S10; Biospace Co., Ltd, Seoul, Korea),
with participants in supine position, and expressed as (a)
skeletal muscle mass (SMM) in kg, (b) SMM index (SMI:
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SMM/height2) in kg/m2, (c) SMM relative to body weight
(relative SMM: SMM/weight × 100) in %, (d) appendicular
lean mass (ALM) in kg, (e) ALM/height2 in kg/m2, (f) ALM
relative to body weight (relative ALM: ALM/weight × 100)
in %. HGS was measured using a handheld dynamometer
(JAMAR hand dynamometer; Sammons Preston, Inc.,
Bolingbrook, IL, USA), performed 3 times for each hand
(Reijnierse, de Jong, et al., 2017). The best score was used
for analyses and expressed in kilogram. Gait speed was
assessed using a timed 4-m walking test at preferred pace
from a standing start using a stopwatch. The fastest time of
two trials was used for analyses and gait speed was ex-
pressed in meters per second (m/s). Enough space was al-
lowed after the walking track to minimize deceleration
during the 4-m walking test. Data on muscle mass, HGS, and
gait speed were missing in nine, four, and five participants,
respectively. The EWGSOP definition of sarcopenia was
used, including sex-specific cut-off points for low SMI
(≤10.75 kg/m2 for males and ≤6.75 kg/m2 for females),
combined with low HGS (<30 kg for males and <20 kg for
females) and/or low gait speed (≤0.80 m/s for both males
and females; Cruz-Jentoft et al., 2010).
Statistical analysis. Descriptive statistics were visualized using
GraphPad Prism for Windows (Version 7.0. GraphPad Soft-
ware, Inc.). Normality of the variables was checked and pre-
sented as mean with SD for normally distributed variables,
number with % for categorical variables and median with in-
terquartile range (IQR) for skewed variables. The objective
muscle measures were standardized using sex-specific z scores
to account for gender differences. The awareness of muscle
health was tested using Pearson’s bivariate and partial corre-
lations between self-perceivedmuscle health and the z scores of
objective muscle measures, controlling for age and number of
morbidities. Pearson correlations < .3 were considered negli-
gible, .3-.5 were considered low, and ≥.5 were considered
moderate to high (Mukaka, 2012). Analyses were performed
using the Statistical Package for the Social Sciences (IBMSPSS
Statistics forWindows, Version 23.0. Armonk, NY, IBMCorp).
Results
Participant characteristics are shown in Table 1. The median
age of the participants was 67.9 years (IQR = 57.0-75.1).
Seventy-one percent of the participants were female. Partic-
ipants had a mean educational level of 18.4 years (SD = 4.8).
Terminology
Thirty-four participants (17%) stated to have heard of the
term sarcopenia. Fifty-seven participants (29%) answered to
have heard of the Dutch lay term for sarcopenia “Spier-
armoede.” Eighteen participants (9%) reported to know the
definition of sarcopenia. Participants thought that sarcopenia
was related to muscles (43%), brain (15%), and bones (14%).
Etiology
Indicated causes of sarcopenia are shown in Figure 1. Correct
answers were selected, namely, aging (24%), malnutrition
(19%), and physical inactivity (25%). Participants also se-
lected high blood pressure (4%), use of medication (10%),
and obesity (17%) as causes of sarcopenia. Figure 2 shows the
distribution of the age at which participants thought muscle
mass starts to decline, with a mean age of 46.2 years, (SD =
15.5). Twenty-four percent thought the decline starts before
the age of 30 years, and 27% thought it starts after the age of
60 years. High VAS scores were given to the importance of
muscles for overall health, for independency at older age, the
importance of physical activity and nutrition for maintaining
muscle (Figure 3).
Consequences
Figure 1 shows the indicated consequences of sarcopenia.
Correct answers were selected, namely, falls (33%), fractures
(26%), and admission to a nursing home (11%). Participants
also selected dehydration (1%), dementia (3%), loss of vision
(2%), and pain in the upper legs (20%) as consequences of
sarcopenia.
Table 1. Participant Characteristics of the “Sarcopenia
Awareness Show.”
Characteristics Total (n = 197)
Age, years, Mdn (IQR) 67.9 (57.0-75.1)
Sex, female 140 (71.1)
Retired 129 (65.5)
Career in health care 61 (31.3)
Education, years, M (SD) 18.4 (4.8)
Current smoking 6 (3.1)
Alcohol use 172 (88.2)
Muscle strengthening exercises ≥ 2 times per
week
138 (70.1)
Moderate-vigorous activities ≥ 150 min per week 168 (85.3)
Use of walking aid 8 (4.1)
Difficulty walking 100 m 9 (4.6)
Falls in previous 12 months 50 (25.4)




Weight, kg, M (SD) 73.0 (12.5)
Height, cm, M (SD) 169.7 (9.3)
BMI, kg/m2, M (SD) 25.4 (3.8)
Sarcopeniac 10 (5.3)
Note. All variables are presented as n (%), unless otherwise indicated. n =
number of participants; IQR = interquartile range; ADL = activities of daily
living; BMI = body mass index.
aNumber of medications > 4.
bNumber of morbidities > 1.
cEuropean Working Group on Sarcopenia in older people definition (Cruz-
Jentoft et al., 2010).
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Treatment
The correct answers for the appropriate treatment of sar-
copenia, for example, a high protein diet (14%) and muscle
strength training (21%), were chosen, as well as balance
training (18%), cardiovascular training (20%) and eating
more vegetables and fruit (13%; Figure 1). After participants
were informed about the correct treatment, the largest
proportion stated to be willing to start both a high protein
diet and muscle strength training (76%) in case they would
be diagnosed with sarcopenia. An overview of the reported
obstacles for treatment of sarcopenia is provided in Table 2.
Forty-four percent of participants reported obstacles, and
most frequently reported time constraints (32%), expenses
(23%), and aversion of visiting a health care professional
(15%) as obstacles.
Prevention
Seventy-one percent of participants were willing to increase
both their protein intake and physical activity levels to
prevent the development of sarcopenia. Other participants
indicated they only wanted to increase protein intake (7%)
or physical activity (14%). Eight percent of participants in-
dicated not willing to prevent the development of sarcopenia.
After exclusion of 10 participants (5%) that met the EWG-
SOP criteria for sarcopenia (Cruz-Jentoft et al., 2010), these
percentages did not change.
Awareness
The correlation between self-perceived muscle health and the
objective muscle measures are shown in Table 3. The
Figure 1. Knowledge in community-dwelling adults about indicated causes, consequences, and treatment of sarcopenia.
Figure 2. Distribution of the age at which participants thought
muscle mass starts to decline.
Note. Dotted line represents the third decade of life (Doherty, 2001).
Figure 3. Rating of the importance of items related to muscle.
Note. Box represents median; error bars: interquartile range. VAS = visual
analog scale.
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correlations were negligible for muscle mass (range r = .18-
.29), HGS (r = .12, p = .092) and gait speed (r = .19, p = .008).
Controlling for age and number of morbidities did not change
the results. Two of the 10 participants that met the EWGSOP
criteria for sarcopenia indicated to have sarcopenia. Seventeen
participants (10%) that did not meet the EWGSOP criteria for
sarcopenia thought to have sarcopenia. The number of par-
ticipants with sarcopenia is visualized in Figure 4 using the
EWGSOP flowchart (Cruz-Jentoft et al., 2010).
Discussion
In a cohort of community-dwelling adults, the knowledge
about etiology and consequences of sarcopenia was limited.
Although participants acknowledged the importance of
muscle health and generally expressed willingness to treat
sarcopenia, or change lifestyle to prevent the development of
sarcopenia, the awareness of their own muscle health was
low, as self-perceived muscle health did not correlate with
objectively measured muscle measures.
Only few community-dwelling adults stated to know
what sarcopenia is. In previous studies among health care
professionals, 70% stated to know the concept of sarcopenia,
whereas only 13%-21% stated to know how to diagnose
sarcopenia (Reijnierse, de van der Schueren, et al., 2017;
Yeung et al., unpublished data). In comparison, studies in-
vestigating the knowledge about osteoporosis in community-
dwelling adults have showed that over 85% to 90% of the
participants know about this disease (Kasper, Peterson, &
Allegrante, 2001; Kasper, Peterson, Allegrante, Galsworthy,
& Gutin, 1994; Ungan & Tumer, 2001). Sarcopenia is an
unfamiliar term in community-dwelling Dutch adults, con-
sidering it was only recently recognized as a disease (Anker
et al., 2016), and has not yet received frequent public notice.
Participants thought that the decline of muscle mass starts at
a rather late age (on average 46 years), instead of the third
decade (Doherty, 2001). This misguided conception may be
a result of the maintenance of physical performance until
a later age (Rojer et al., 2017). Out of different types of
exercise and dietetic options, the majority of the participants
could not identify the appropriate treatment for sarcopenia.
However, correct causes and consequences of sarcopenia
were selected, and, additionally, the importance of muscle
health for overall health and independency was recognized,
indicated by the high VAS scores.
The combination of muscle strength training and protein
consumption has been shown to be effective interventions to
counteract sarcopenia (Kim et al., 2012; Tieland et al., 2012).
Recommendations include intensive muscle strength training
3 times a week (Montero-Fernandez & Serra-Rexach, 2013;
Peterson et al., 2010) and protein supplementation during
three meals per day (Paddon-Jones & Rasmussen, 2009). The
majority of participants indicated that they were willing to
prevent sarcopenia, and in case of diagnosis of sarcopenia to
comply with treatment.
Table 2. Potential Obstacles for Treatment of Sarcopenia.
n (%)
Obstacles reported, yes 84 (43.8)
Reported obstacles (multiple answers possible)
Treatment is too time-consuming 36 (31.9)
Treatment could be expensive 26 (23.0)
I don’t like to go to health care professionals 17 (15.0)
The consequences of sarcopenia are not severe
enough
14 (12.4)
Health care professionals are too far away 6 (5.3)
Other obstacles reported 14 (12.4)
Table 3. Descriptives and Pearson’s Correlations of Objective Muscle Measures and Self-Perceived Muscle Health.
Descriptives (n = 197), M (SD)
Bivariate correlation,a r (p) Partial correlation,a,b r (p)Male (n = 57) Female (n = 140)
Self-perceivedc 72.8 (16.7) 68.1 (19.1)
Objective
SMM, kg 33.5 (5.1) 24.9 (3.2) .25 (.001) .25 (.001)
SMI, kg/m2 10.4 (1.2) 9.1 (1.0) .25 (.001) .27 (<.001)
SMM, % 40.8 (3.9) 36.6 (4.7) .29 (<.001) .28 (<.001)
ALM, kg 26.8 (4.0) 19.4 (2.7) .18 (.014) .19 (.011)
ALM/height2, kg/m2 8.3 (0.8) 7.1 (0.8) .19 (.011) .22 (.003)
ALM, % 32.6 (3.0) 28.4 (3.5) .24 (.001) .20 (.009)
HGS, kg 38.0 (9.9) 27.4 (7.5) .12 (.092) .10 (.198)
Gait speed, m/s 1.3 (0.3) 1.3 (0.2) .19 (.008) .13 (.083)
Note. SMM = skeletal muscle mass; SMI = skeletal muscle index; ALM = appendicular lean mass; HGS = hand grip strength.
aUsing sex-specific z scores of objective muscle measures.
bControlled for age and morbidities.
cSelf-perceived muscle health, scored using a 100-mm visual analog scale.
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In contrast to their acknowledgment of the importance of
muscle health, participants seemed largely unaware of their
own muscle health considering the low correlations between
self-perceived ratings and objective measures. In addition, we
observed a minimal overlap between their assumption and
actually having sarcopenia, with indication for both over- and
underestimation. Awareness on muscle health may increase
with increasing knowledge. These findings highlight the
necessity for objective measures to assess muscle health and
diagnose sarcopenia.
To the best of our knowledge, this is the first study addressing
the knowledge about sarcopenia in a community-dwelling co-
hort. In absence of a validated disease-specific questionnaire to
measure knowledge about sarcopenia, a custom questionnaire
had to be developed. This is a limitation to this study, as content,
concurrent, and construct validity of the questionnaire could not
be tested. Some other limitations should be addressed. Multiple-
choice questions were used to minimize bias from missing
data, but may have provided desirable answers compared
with individual answers to open questions. Selection bias
by attracting mostly highly educated participants with
probably relatively high levels of physical activity and low
prevalence of sarcopenia could not be avoided due to the
specific study setting. No follow-up assessment was per-
formed to address retention of knowledge.
Preventing rather than counteracting sarcopenia would
strongly reduce negative health outcomes and health care
burden. Current evidence shows that prevention of sarcopenia
is of most importance for healthy aging (Brown et al., 2016;
Dos Santos et al., 2017; Landi et al., 2012; Tang et al., 2018; Yu
et al., 2014). Education has been shown to increase knowledge
and raise awareness, and encourage people to improve their
lifestyle (Brunello, Fort, Schneeweis, & Winter-Ebmer, 2016;
Cusack, Del Mar, Chalmers, Gibson, & Hoffmann, 2018; Li &
Powdthavee, 2015). A previous study on osteoporosis pre-
vention highlighted the need for more comprehensive and
personalized education complementary to class room–based
education (Gaines, Narrett, & Parrish, 2010). Our findings
indicate that in community-dwelling adults, education should
focus on extending knowledge about the terminology, the need
for timely prevention given the early decline of muscle mass,
and appropriate treatment to counteract sarcopenia. A con-
siderable role in the education lies with the health care pro-
fessional, of which the majority states to be acquainted with
sarcopenia (Reijnierse, de van der Schueren, et al., 2017).
Future studies should investigate if educational activities in-
crease knowledge about sarcopenia and raise muscle health
awareness, and whether this could lead to prevention of sar-
copenia and reduction of health care burden.
In conclusion, in a cohort of community-dwelling adults with
a high mean education, we demonstrated limited knowledge
about sarcopenia and one’s own muscle health. In contrast, the
assumed importance of muscle health and willingness to treat
and prevent were acknowledged, showing the potential benefits
of targeted educational programs to improve prevention and
timely intervention.
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